19th Jun 2015 11:25
UK stocks advanced on Friday as investors shrugged off a disappointing end to the Eurogroup meeting on Greece, and instead sought out bargains following the recent sell-off. The FTSE 100, which dropped to levels not seen since January earlier in the week, was trading up 0.54% at 6,744.20 by midday.
Read more19th Jun 2015 08:56
Pharmaceuticals group Hikma was a high riser on the FTSE 100 on Friday after analysts at Citigroup upgraded the stock from 'neutral' to 'buy', recommending investors "keep the faith" despite a recent drop in the shares. The stock has plunged over 25% since Citi's downgrade to 'neutral' in late Febru
Read more19th Jun 2015 08:29
UK stocks edged higher on Friday morning despite a bleak outcome to the Eurogroup meeting, as finance minsters failed to come up with proposals to solve the Greek debt crisis. However, given that expectations were low going into Thursday's meeting, disappointment may have already been priced in, ana
Read more18th May 2015 13:14
Shares in Hikma Pharmaceuticals were under pressure on Monday, down 2% after the company said its founder and major shareholder, Samih Darwazah, passed away last Friday at the age of 85. Hikma floated on the London Stock Exchange in 20105 and entered the FTSE 100 index in March 2015, replacing Tullo
Read more14th May 2015 16:44
After a negative start, UK stocks rallied into the close as improving labour-market data from the States lifted sentiment. After a choppy week, owing mainly to volatility on the government bond market, Wall Street indices opened higher following a Labor Department report which showed that US jobless
Read more14th May 2015 12:56
UK stocks rebounded from early losses, but remained restrained by concerns of Greek instability. Sector wise, miners and technology services provided the biggest drag, while insurers and utilities gave a welcome boost. At 1:45 BST, the FTSE 100 was trading 12 points higher at 6,962. ITV declined a
Read more14th May 2015 11:34
UK stocks erased losses by Thursday lunchtime on a quiet session for economic data, though concerns about Greece were limiting upside. Reports that Greek finance minister Yanis Varoufakis has called for the European Central Bank to delay Athens' debt repayments shook sentiment among investors. The
Read more14th May 2015 09:12
Hikma Pharmaceuticals said it had enjoyed a good start to the year and said revenues at its Injectables division would remain at a similar level to last year's but with a slight decline in operating profit margins. Ahead of its annual shareholder meeting on Thursday, the FTSE 100 group reiterated it
Read more14th May 2015 08:15
UK shares declined on Thursday morning ahead of a quiet session in terms of economic data, with corporate earnings coming in mixed and a number of ex-dividend stocks in the red. The FTSE 100 was down 0.58% at 6,909.22 early on. Global stock markets closed in a mixed fashion on Wednesday on the back
Read more12th May 2015 13:41
Hikma Pharmaceuticals on Tuesday launched a caffeine citrate injection to treat apnea resulting from prematurity in infants of between 28 and 33 weeks of gestational age. The company noted that sales of caffeine citrate injections in the US last year were of $7.6m. Chairman and chief executive Said
Read more20th Mar 2015 16:52
Dovish central banks and fading worries about Greece exiting the Eurozone propelled the London market to record fresh all-time highs on Friday. At Friday's close, the FTSE 100 index stood strong at 7022.51, up 0.8% on the day, off a touch from its session high of 7024.21. "The FTSE 100's landmark m
Read more20th Mar 2015 13:45
Vedanta Resources topped the risers, despite cutting its capital expenditure budget for 2015 by $400m and halving its 2016 budget. Miners Lonmin and Kaz Minerals were making gains on the rising three-month copper futures, which were 1.5% higher. Ophir Energy was boosted as investment analysts at De
Read more17th Mar 2015 15:30
Middle East focused Hikma Pharmaceuticals is reportedly planning to sell its first benchmark-sized dollar bonds, according to two people familiar with the sale. Bloomberg News on Tuesday cited sources close to the deal in its report. Shares in Hikma fell 1.8% to 2217p on the back of the report, as m
Read more12th Mar 2015 18:16
Hikma Pharmaceuticals' decision not to sell its injectables business is probably one of the savviest decisions the company has taken in the last few years. The price-tag mooted was $2bn. More importantly, it put the little-known firm on many investors' radars. That unit saw its sales in the US rise
Read more11th Mar 2015 13:42
Japan-based office equipment supplier Brother Industries has agreed to acquire British printing technology company Domino Printing Sciences for £1.03bn, unleashing a 32% surge in the share price. Domino, which has operations in the UK, China, Germany, India, Sweden and the US, will continue to opera
Read more